메뉴 건너뛰기




Volumn 29, Issue 2, 2004, Pages 103-106

Bioequivalence evaluation of two rabeprazole enteric coated formulations in healthy Chinese volunteers

Author keywords

Bioequivalence; Pharmacokinetics; Rabeprazole

Indexed keywords

RABEPRAZOLE;

EID: 3042664031     PISSN: 03787966     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03190583     Document Type: Article
Times cited : (8)

References (8)
  • 1
    • 0029012689 scopus 로고
    • The proton pump inhibitor, E3810, binds to the N-terminal half of the alpha-subunit of gastric H+,K(+)-ATPase
    • Morii M., Hamatani K., Takeguchi N (1995): The proton pump inhibitor, E3810, binds to the N-terminal half of the alpha-subunit of gastric H+,K(+)-ATPase. Biochem. Pharmcol., 49, 1729-1734
    • (1995) Biochem. Pharmcol. , vol.49 , pp. 1729-1734
    • Morii, M.1    Hamatani, K.2    Takeguchi, N.3
  • 2
    • 0031892875 scopus 로고    scopus 로고
    • Rabeprazole
    • Prakash A., Faulds D. (1998): Rabeprazole. Drugs., 55, 261-267
    • (1998) Drugs , vol.55 , pp. 261-267
    • Prakash, A.1    Faulds, D.2
  • 3
    • 0035691477 scopus 로고    scopus 로고
    • Rabeprazole: An update of its use in acid-related disorders
    • Carswell CI., Goa KL. (2001): Rabeprazole: an update of its use in acid-related disorders. Drugs., 61, 2327-2356.
    • (2001) Drugs , vol.61 , pp. 2327-2356
    • Carswell, C.I.1    Goa, K.L.2
  • 4
    • 0036712557 scopus 로고    scopus 로고
    • Rabeprazole: Pharmacokinetics and pharmacokinetic drug interactions
    • Fuhr U., Jetter A. (2002): Rabeprazole: pharmacokinetics and pharmacokinetic drug interactions. Pharmazie., 57, 595-601.
    • (2002) Pharmazie , vol.57 , pp. 595-601
    • Fuhr, U.1    Jetter, A.2
  • 5
    • 0033014908 scopus 로고    scopus 로고
    • Rabeprazole: Pharmacokinetics in patients with stable, compensated cirrhosis
    • Hoyumpa AM., Trevino-Alanis H., Grimes I., Humphries TJ. (1999): Rabeprazole: pharmacokinetics in patients with stable, compensated cirrhosis. Clin Ther., 21, 691-701
    • (1999) Clin Ther. , vol.21 , pp. 691-701
    • Hoyumpa, A.M.1    Trevino-Alanis, H.2    Grimes, I.3    Humphries, T.J.4
  • 6
    • 0033341631 scopus 로고    scopus 로고
    • Rabeprazole: Pharmacokinetics and tolerability in patients with stable, end-stage renal failure
    • Keane WF., Swan SK., Grimes I., Humphries TJ. (1999): Rabeprazole: pharmacokinetics and tolerability in patients with stable, end-stage renal failure. J Clin Pharmacol., 39, 927-933
    • (1999) J. Clin. Pharmacol. , vol.39 , pp. 927-933
    • Keane, W.F.1    Swan, S.K.2    Grimes, I.3    Humphries, T.J.4
  • 7
    • 0028149206 scopus 로고
    • Determination of a new H(+)-K+ ATPase inhibitor (E3810) and its four metabolites in human plasma by high-performance liquid chromatography
    • Nakai H., Shimamura Y., Kanazawa T., Yasuda S., Kayano M. (1994): Determination of a new H(+)-K+ ATPase inhibitor (E3810) and its four metabolites in human plasma by high-performance liquid chromatography. J Chromatogr B Biomed Appl., 660, 211-220
    • (1994) J. Chromatogr. B Biomed. Appl. , vol.660 , pp. 211-220
    • Nakai, H.1    Shimamura, Y.2    Kanazawa, T.3    Yasuda, S.4    Kayano, M.5
  • 8
    • 0028811030 scopus 로고
    • Enantioselective high-performance liquid chromatographic assay for determination of the enantiomers of a new anti-ulcer agent, E3810, in beagle dog plasma and rat plasma
    • Takakuwa S., Chiku S., Nakata H., Yuzuriha T., Mano N., Asakawa N. (1995): Enantioselective high-performance liquid chromatographic assay for determination of the enantiomers of a new anti-ulcer agent, E3810, in beagle dog plasma and rat plasma. J Chromatogr B Biomed Appl., 673, 113-122.
    • (1995) J. Chromatogr. B Biomed. Appl. , vol.673 , pp. 113-122
    • Takakuwa, S.1    Chiku, S.2    Nakata, H.3    Yuzuriha, T.4    Mano, N.5    Asakawa, N.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.